Figure 2

Analysis of somatic mutations in plasma circulating tumor DNA by CAPP-Seq. Alterations of the mutant allele in nine patients before and 4 weeks after afatinib treatment, and at the development of disease progression (A–I).
Analysis of somatic mutations in plasma circulating tumor DNA by CAPP-Seq. Alterations of the mutant allele in nine patients before and 4 weeks after afatinib treatment, and at the development of disease progression (A–I).